1252 related articles for article (PubMed ID: 25870282)
21. Selective preservation of cholinergic MeCP2 rescues specific Rett-syndrome-like phenotypes in MeCP2
Zhou H; Wu W; Zhang Y; He H; Yuan Z; Zhu Z; Zhao Z
Behav Brain Res; 2017 Mar; 322(Pt A):51-59. PubMed ID: 28093257
[TBL] [Abstract][Full Text] [Related]
22. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
Peddada S; Yasui DH; LaSalle JM
Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435
[TBL] [Abstract][Full Text] [Related]
23. Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome.
McGill BE; Bundle SF; Yaylaoglu MB; Carson JP; Thaller C; Zoghbi HY
Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18267-72. PubMed ID: 17108082
[TBL] [Abstract][Full Text] [Related]
24. Mecp2-null mice provide new neuronal targets for Rett syndrome.
Urdinguio RG; Lopez-Serra L; Lopez-Nieva P; Alaminos M; Diaz-Uriarte R; Fernandez AF; Esteller M
PLoS One; 2008; 3(11):e3669. PubMed ID: 18989361
[TBL] [Abstract][Full Text] [Related]
25. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
Kaufmann WE; Johnston MV; Blue ME
Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
[TBL] [Abstract][Full Text] [Related]
26. Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.
Giacometti E; Luikenhuis S; Beard C; Jaenisch R
Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1931-6. PubMed ID: 17267601
[TBL] [Abstract][Full Text] [Related]
27. Structural Basis of MeCP2 Distribution on Non-CpG Methylated and Hydroxymethylated DNA.
Sperlazza MJ; Bilinovich SM; Sinanan LM; Javier FR; Williams DC
J Mol Biol; 2017 May; 429(10):1581-1594. PubMed ID: 28450074
[TBL] [Abstract][Full Text] [Related]
28. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation.
Zhou Z; Hong EJ; Cohen S; Zhao WN; Ho HY; Schmidt L; Chen WG; Lin Y; Savner E; Griffith EC; Hu L; Steen JA; Weitz CJ; Greenberg ME
Neuron; 2006 Oct; 52(2):255-69. PubMed ID: 17046689
[TBL] [Abstract][Full Text] [Related]
29. Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons.
Tao J; Wu H; Sun YE
Int Rev Neurobiol; 2009; 89():147-60. PubMed ID: 19900619
[TBL] [Abstract][Full Text] [Related]
30. PTP1B inhibition suggests a therapeutic strategy for Rett syndrome.
Krishnan N; Krishnan K; Connors CR; Choy MS; Page R; Peti W; Van Aelst L; Shea SD; Tonks NK
J Clin Invest; 2015 Aug; 125(8):3163-77. PubMed ID: 26214522
[TBL] [Abstract][Full Text] [Related]
31. Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons.
Yazdani M; Deogracias R; Guy J; Poot RA; Bird A; Barde YA
Stem Cells; 2012 Oct; 30(10):2128-39. PubMed ID: 22865604
[TBL] [Abstract][Full Text] [Related]
32. Rett syndrome - biological pathways leading from MECP2 to disorder phenotypes.
Ehrhart F; Coort SL; Cirillo E; Smeets E; Evelo CT; Curfs LM
Orphanet J Rare Dis; 2016 Nov; 11(1):158. PubMed ID: 27884167
[TBL] [Abstract][Full Text] [Related]
33. Emerging physiological and pathological roles of MeCP2 in non-neurological systems.
Wang J; Xiao Y; Liu C; Huang Y; Petersen RB; Zheng L; Huang K
Arch Biochem Biophys; 2021 Mar; 700():108768. PubMed ID: 33485848
[TBL] [Abstract][Full Text] [Related]
34. Disruption of MeCP2 attenuates circadian rhythm in CRISPR/Cas9-based Rett syndrome model mouse.
Tsuchiya Y; Minami Y; Umemura Y; Watanabe H; Ono D; Nakamura W; Takahashi T; Honma S; Kondoh G; Matsuishi T; Yagita K
Genes Cells; 2015 Dec; 20(12):992-1005. PubMed ID: 26456390
[TBL] [Abstract][Full Text] [Related]
35. P152R Mutation Within MeCP2 Can Cause Loss of DNA-Binding Selectivity.
Franklin D
Interdiscip Sci; 2019 Mar; 11(1):10-20. PubMed ID: 30673959
[TBL] [Abstract][Full Text] [Related]
36. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
[TBL] [Abstract][Full Text] [Related]
37. MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain.
Nguyen MV; Du F; Felice CA; Shan X; Nigam A; Mandel G; Robinson JK; Ballas N
J Neurosci; 2012 Jul; 32(29):10021-34. PubMed ID: 22815516
[TBL] [Abstract][Full Text] [Related]
38. An optogenetic mouse model of rett syndrome targeting on catecholaminergic neurons.
Zhang S; Johnson CM; Cui N; Xing H; Zhong W; Wu Y; Jiang C
J Neurosci Res; 2016 Oct; 94(10):896-906. PubMed ID: 27317352
[TBL] [Abstract][Full Text] [Related]
39. MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome.
Tai DJ; Liu YC; Hsu WL; Ma YL; Cheng SJ; Liu SY; Lee EH
Nat Commun; 2016 Feb; 7():10552. PubMed ID: 26842955
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis questions the role of MeCP2 as a global regulator of alternative splicing.
Chhatbar K; Cholewa-Waclaw J; Shah R; Bird A; Sanguinetti G
PLoS Genet; 2020 Oct; 16(10):e1009087. PubMed ID: 33048927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
